Global University Venturing

The combined value of Woodford's stakes in immunotherapy developer Immunocore has reportedly crashed to $57m from around $112m.

The total size of investments from the Cambridge-allied patient capital fund rose from $45.8m in 2017-2018, following a $196m fundraising effort earlier this year.

Imec.xpand has co-led a $7m seed round for Pharrowtech, which is commercialising millimeter wave wireless technology based on research at Imec and Vrije Universiteit Brussel.

Stanford's Atreca floated in the middle of its range and will use the funding to advance its lead cancer immunotherapeutic canadidate through the clinic.

Lab10x will accelerate the commercialisation of digital therapeutics and data-driven drug discovery, and is being launched in partnership with Sensyne Health and Evotec.

Taiho Ventures has supplied a $10m extension for Caltech spinout Axial Biotherapeutics’ series B, bringing the total to $35m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank is reportedly considering an investment of between $200m and $350m in CureFit, whose existing investors include the University of California-backed UC-RNT Fund.

UT Austin-founded graph data developer Capsenta has been picked up by Data.world, which has integrated the spinout’s technology with its own product.

Harvard's Root Robotics markets an educational coding robot that teaches children about computer programming and has now been acquired by iRobot for an unspecified amount.

Building on joint research from University of Vienna and Medical University of Vienna, P4 is creating next-generation platinum chemotherapy with fewer side-effects than current approaches.